AR107315A2 - HUMANIZED ANTIBODY - Google Patents
HUMANIZED ANTIBODYInfo
- Publication number
- AR107315A2 AR107315A2 ARP170100039A ARP170100039A AR107315A2 AR 107315 A2 AR107315 A2 AR 107315A2 AR P170100039 A ARP170100039 A AR P170100039A AR P170100039 A ARP170100039 A AR P170100039A AR 107315 A2 AR107315 A2 AR 107315A2
- Authority
- AR
- Argentina
- Prior art keywords
- humanized antibody
- amyloidosis
- alzheimer
- chimeric
- disorders
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 102000009091 Amyloidogenic Proteins Human genes 0.000 abstract 1
- 108010048112 Amyloidogenic Proteins Proteins 0.000 abstract 1
- 230000005856 abnormality Effects 0.000 abstract 1
- 206010002022 amyloidosis Diseases 0.000 abstract 1
- 208000035474 group of disease Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La presente solicitud está relacionada con anticuerpos quiméricos y humanizados y métodos y composiciones para uso terapéutico y de diagnóstico en el tratamiento de amiloidosis, un grupo de trastornos y anormalidades asociadas con la proteína amiloide, tal como la enfermedad de Alzheimer.The present application is related to chimeric and humanized antibodies and methods and compositions for therapeutic and diagnostic use in the treatment of amyloidosis, a group of disorders and abnormalities associated with amyloid protein, such as Alzheimer's disease.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06014730 | 2006-07-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR107315A2 true AR107315A2 (en) | 2018-04-18 |
Family
ID=41040485
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP170100039A AR107315A2 (en) | 2006-07-14 | 2017-01-06 | HUMANIZED ANTIBODY |
| ARP180102374A AR112975A2 (en) | 2006-07-14 | 2018-08-21 | HUMANIZED ANTIBODY |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP180102374A AR112975A2 (en) | 2006-07-14 | 2018-08-21 | HUMANIZED ANTIBODY |
Country Status (3)
| Country | Link |
|---|---|
| AR (2) | AR107315A2 (en) |
| UA (1) | UA100672C2 (en) |
| ZA (1) | ZA200900313B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3166970T3 (en) * | 2014-07-10 | 2021-09-13 | Bioarctic Ab | Improved a-beta protofibril binding antibodies |
-
2007
- 2007-07-13 UA UAA200900880A patent/UA100672C2/en unknown
-
2009
- 2009-01-14 ZA ZA200900313A patent/ZA200900313B/en unknown
-
2017
- 2017-01-06 AR ARP170100039A patent/AR107315A2/en not_active Application Discontinuation
-
2018
- 2018-08-21 AR ARP180102374A patent/AR112975A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200900313B (en) | 2010-06-30 |
| UA100672C2 (en) | 2013-01-25 |
| AR112975A2 (en) | 2020-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12015500507A1 (en) | Humanized antibodies to amyloid beta | |
| CR20150016A (en) | MONOCLONAL ANTIBODY | |
| WO2008011348A3 (en) | Humanized antibody against amyloid beta | |
| AU2018256498A1 (en) | Antibodies to amyloid beta | |
| MX341369B (en) | Safe and functional humanized anti beta-amyloid antibody. | |
| MX2009013503A (en) | Monoclonal anti beta amyloid antibody. | |
| UA109633C2 (en) | HUMAN ANTIBODY AGAINST TISSUE FACTOR | |
| AR092779A1 (en) | PHARMACEUTICAL COMPOSITION THAT INCLUDES ANTIBODIES THAT JOIN TAU PROTEIN CONFORMERS | |
| AR092818A1 (en) | HUMANIZED TAU ANTIBODY | |
| CR20140496A (en) | HUMANIZED ANTIBODIES AGAINST BETA-AMILOIDS | |
| ECSP13012436A (en) | BETA AMILOID ANTI-N3pGlu PEPTIDE ANTIBODIES AND USES OF THE SAME | |
| CL2014000679A1 (en) | Tau binding antibody; vector; host cell; hybridoma; peptide comprising epitope of tau; pharmaceutical composition comprising the antibody or tau peptide; medical device to administer them; use to treat, prevent or diagnose Alzheimer's disease or related tautology; and method to produce antibody | |
| EP2650308A3 (en) | Use of anti-amyloid beta antibody in ocular diseases | |
| WO2008060364A3 (en) | Humani zed antibody against amyloid beta | |
| MX2009005743A (en) | NEW Abeta CONFORMER SELECTIVE ANTI-Abeta GLOBULOMER MONOCLONAL ANTIBODIES. | |
| EA200702053A1 (en) | ANTIBODIES AGAINST CD38 FOR THE TREATMENT OF MULTIPLE MYELOMA | |
| EP2586795A3 (en) | Use of anti-amyloid beta antibody in ocular diseases | |
| WO2010012004A3 (en) | Monoclonal antibodies specific for pathological amyoid aggregates common to amyloids formed from proteins of differing sequence | |
| DOP2012000232A (en) | SPECIFIC ANTIGEN BINDING PROTEINS FOR SERICO P AMILOID COMPONENT | |
| AR112975A2 (en) | HUMANIZED ANTIBODY | |
| WO2009120659A3 (en) | Human monoclonal antibodies against amyloid beta protein, and their use as therapeutic agents | |
| WO2009120657A3 (en) | Human monoclonal antibodies against amyloid beta protein, and their use as therapeutic agents | |
| EA202190387A1 (en) | ANTIBODY TO HUMAN CD38 AND ITS USE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |